Free Trial

Top 20 New Entrants companies in Inositol
by Most Patent Filing In 5 Years in the United States in 2018

The Inositol top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filing In 5 Years Inositol New Entrants in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Inositol, or more precisely myo-inositol, is a carbocyclic sugar that is abundant in brain and other mammalian tissues, mediates cell signal transduction in response to a variety of hormones, neurotransmitters and growth factors and participates in osmoregulation. It is a sugar alcohol with half the sweetness of sucrose (table sugar). It is made naturally in humans from glucose. A human kidney will produce around two grams each day. Other tissues synthesize it too, and the highest concentration is in the brain where it plays an important role making other neurotransmitters and some steroid hormones bind to their receptors. In the last 10 years, myo-inositol gained importance in the management of PCOS due to its efficacy, safety profile and worldwide availability.
#
Company Name
Region
Tech Topics
Total
1
Medicine,Pharmacy and Therapeutics,Autoimmune disease,
...[+2]
Patent: 26
2
Patent: 13
3
Library science,Academic department,Professional degree,
...[+2]
Patent: 11
4
Patent: 7
5
Patent: 6
6
Environmental engineering,Environmental consulting
Patent: 6
7
Library science,Work ethic,Psychology,
...[+2]
Patent: 5
8
Stony Brook University
Public university,Incubator,Accounting,
...[+2]
Patent: 5
9
Patent: 5
10
Asset management
Patent: 5
11
Educational program,Biology,Health care,
...[+2]
Patent: 4
12
Biopharmaceutical,Medicine,Health care,
...[+2]
Patent: 4
13
Pracinostat,Medicine,Health care,
...[+2]
Patent: 4
14
Patent: 3
15
MicroLED,Social entrepreneurship,Coronavirus disease 2019 (COVID-19),
...[+2]
Patent: 3
16
Health care,Library science,Medicine,
...[+2]
Patent: 3
17
Patent: 3
18
Patent: 2
19
Braingear Enterprises, Inc.
Patent: 2
20
Cardiovascular agent,Drug marketing,Asset management
Patent: 2
Page generation time: Jun 28 2024